Addex Therapeutics Shares Plunge as Phase 2 Study of ADX71149 Falls Short of Primary Goal
Addex Therapeutics Shares Plunge as Phase 2 Study of ADX71149 Falls Short of Primary Goal
由於 ADX71149 的第二階段研究未達到主要目標，Addex Therapeutics 股價暴跌
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊